ksn.com

Aspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight ...

H1 2026: Finalize formulation and manufacture test product. H1 2026 Initial Phase 1 pharmacokinetic clinical cross-over study. "Our pipeline is focused on research in therapeutic areas where we can ...
The Victoria Advocate

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

NANJING, China, Sept. 5, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets ...
Monthly Prescribing Reference

Sublingual Midazolam/Ketamine Effective for Procedural Sedation During Cataract Surgery

Findings showed MELT-300 was statistically superior to both sublingual midazolam and placebo for providing successful procedural sedation. Topline results were announced from a phase 3 trial ...
manilatimes

Zealthy ED Platform in 2026 (Including Hardies Sublingual Formulations): Telehealth ED Treatment Options, Compounded Medication Pricing, and What Consumers Should Verify Before ...

Informational consumer guide examines Zealthy's online ED treatment model, sublingual Hardies formulations, provider evaluation process, subscription structure, and compounded medication disclosures ...